Eldering E, Nuijens J H, Hack C E
Central Laboratory, Netherlands Red Cross Blood Transfusion Service, Amsterdam.
J Biol Chem. 1988 Aug 25;263(24):11776-9.
Full length human C1 inhibitor cDNA was cloned into a vector suitable for transient expression in COS-1 cells. Transfected COS cells secreted an immunoreactive protein of Mr approximately 110,000 that appeared to be functionally equivalent to the plasma-derived protein as established by the following criteria: 1) ability to form sodium dodecyl sulfate-stable complexes with C1s, factor XIIa, and kallikrein; 2) inhibition of C1s-mediated C4 consumption; and 3) susceptibility to inactivation by the nontarget proteinase elastase. Quantitation of secreted recombinant C1 inhibitor by radioimmunoassay indicated that 72 h after transfection the level was approximately 2.2 micrograms/ml. Treatment of transfected cells with tunicamycin resulted in secretion of a protein of Mr approximately 90,000 that was also capable of complex formation with C1s.
将全长人C1抑制剂cDNA克隆到适合在COS-1细胞中瞬时表达的载体中。转染后的COS细胞分泌出一种免疫反应性蛋白,其分子量约为110,000,根据以下标准,该蛋白在功能上似乎等同于血浆来源的蛋白:1)与C1s、因子XIIa和激肽释放酶形成十二烷基硫酸钠稳定复合物的能力;2)抑制C1s介导的C4消耗;3)对非靶蛋白酶弹性蛋白酶失活敏感。通过放射免疫测定法对分泌的重组C1抑制剂进行定量分析表明,转染后72小时其水平约为2.2微克/毫升。用衣霉素处理转染细胞导致分泌出一种分子量约为90,000的蛋白,该蛋白也能够与C1s形成复合物。